|Bid||0.3060 x 50000|
|Ask||0.3340 x 48000|
|Day's Range||0.3120 - 0.3120|
|52 Week Range||0.1720 - 0.6900|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (SPR.CN) (38G.F) (SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the first quarter ended May 31, 2019. "We are off to a strong start in 2020 with the completion of our first quarter, which saw us sign the definitive agreement with Moosehead and make advancements in cultivation and R&D.” said Keith Dolo, Chief Executive Officer of Sproutly. Preparations are advancing towards the launch of our CALIBER premium branded flower and oil, as well as beverages and edibles in line with the proposed regulations recently announced by Health Canada.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to provide an update on its recent cannabis production results at its wholly-owned subsidiary Toronto Herbal Remedies Inc. (“THR”). The total cultivation output for the three-month period ended June 30, 2019 was 298kg of dried cannabis flower, representing a overperformance of 49.9%, relative to the design of 199kg which is based on 2lbs per light.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to provide an update on its premium cannabis brand for the recreational market, CALIBER, as it plans to launch premium cannabis oil products utilizing its BioNatural Oil (“BNO”), a unique and differentiated cannabis oil produced by Sproutly’s proprietary Aqueous Phytorecovery Process (“APP Technology”). Sproutly intends to expand the CALIBER brand of products initially into oil capsules, which will be packaged in child resistant, 30 capsule jars. BNO is recovered using the Company’s proprietary APP Technology.
Sproutly Canada, Inc. (SPR.CN) (38G.F) (SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the year ended February 28, 2019. After going public in July of 2018, we acquired Infusion Biosciences Canada and SSM partners, providing us with access to their ground-breaking APP technology to produce water-soluble cannabinoids (“Infuz2O”) and oil-based cannabinoids (“Bio Natural Oil”) which provides the Company with a differentiating proprietary technology to compete in the infused beverage and edible category. In 2019 we also completed our GTA production facility, received our cultivation license from Health Canada and began full-scale production of all 13 grow rooms” said Keith Dolo, Chief Executive Officer of Sproutly.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that it has successfully completed the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc. at its wholly-owned Toronto Herbal Remedies Inc. (“THR”) licensed facility. This initial APP run successfully recovered both water-soluble cannabinoids (“Infuz2O”), with onset of effects within approximately 5 minutes and which dissipate within approximately 90 minutes, and oil-based cannabinoids (“Bio Natural Oil”), a strain specific cannabis oil. The initial Infuz2O and Bio Natural Oil recovered is expected to be used for R&D and product formulation purposes for cannabis beverages and edibles within the proposed regulations recently announced by Health Canada.
“Recognizing our first commercial sale to another, well recognized, licensed producer is a milestone that we are very proud of. This shipment marks the beginning of Sproutly’s revenue stream and demonstrates our teams ability to, once again, deliver on our strategy.” - said Keith Dolo, Chief Executive Officer, Sproutly Canada. “As Sproutly awaits our Health Canada inspection to achieve our sales license, we may consider selling more wholesale, high quality craft flower, to ensure a consistent inflow of revenue over the coming months.” – states Dolo. Following the receipt of its sales license from Health Canada, Sproutly plans to sell THR’s premium cannabis flower under the CALIBER brand. CALIBER is designed for the cannabis connoisseur and delivered via Sproutly’s craft cannabis flower production. With high-quality manufacturing process, award-winning genetics and distinct premium packaging, the CALIBER brand is expected to deliver a superior cannabis experience for the cannabis connoisseur.
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly” or the “Company”) is pleased to announce it has completed a voluntary debt for shares settlement agreement with an arm’s length creditor (the “Creditor”) whereby the company has settled outstanding current debt in the amount of $3,537,455 (the “Debt”). In settlement of the Debt, the Company has issued 4,716,606 common shares in the capital of the Company (the “Settlement Shares”) at a price of $0.75 per Settlement Share. The Debt was completely extinguished upon the issuance of the Settlement Shares. The Creditor voluntarily elected to satisfy the Debt with common shares in lieu of cash payment.
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that through its wholly owned subsidiary Toronto Herbal Remedies Inc (“THR”), has submitted an amendment for a sales license for cannabis flower. THR has successfully completed its first packaging run for cannabis flower product and has provided all supporting documents to Health Canada. Following a “compliant” rating after their last inspection earlier this year, THR is now looking forward to their next visit from Health Canada in anticipation of receipt of their sales license.
Chief Executive Officer (“CEO”), Keith Dolo, will present at the Canaccord Genuity 3rd annual cannabis conference on May 14th at the Grand Hyatt in New York. CEO Keith Dolo will present as the Cannastocks2019 Q1 investor conference on May 15th, also in New York. Chief Science Officer (“CSO”), Arup Sen, will present at the Cannabis Drinks Expo at the South San Francisco Conference Center in San Francisco on July 25th.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), will be hosting a conference call with Keith Dolo, CEO of Sproutly, Dr. Arup Sen, Chief Science Officer of Sproutly, and Matthew Oland, Moosehead Breweries Limited executive and incoming CEO of the Joint Venture (defined below), at 9:30am Eastern Time on May 1st, 2019. The purpose of the call will be to discuss the recently announced definitive agreement with OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), to form an exclusive joint venture (the “Joint Venture”). A presentation related to the Joint Venture is available on Sproutly’s website www.sproutly.ca as well as at the download link below.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), are pleased to announce that they have entered into a definitive agreement (the “Joint Venture Agreement”) to form an exclusive joint venture (the “Joint Venture” or the “JV”) to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using Sproutly’s proprietary, naturally produced water soluble cannabinoids known as ‘Infuz2O’. Both companies will bring their respective strengths to the joint venture to develop a line of great tasting cannabis beverages featuring a rapid onset and offset effect unique to the category.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), is pleased to announce that the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”), a licensed producer under the Cannabis Act, has received a processing licence from Health Canada effective March 29, 2019 (the “Processing License”). The Processing License allows THR to produce cannabis oil and related products, and will also allow the Company to conduct certain research and development activities, including the formulation of proprietary beverage products. “We are making steady progress towards achieving Sproutly’s mission of delivering a safe and consistent whole plant experience from cannabis, with a lead position in the beverage market.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to provide a strategic update on the development of its business to date. Sproutly continues to make substantial progress towards its goal of becoming a global cannabis beverage and edibles company. “We have been successful in acquiring the exclusive rights to Infusion Biosciences’ APP technology, in certain jurisdictions, which is able to produce naturally water-soluble cannabinoids that deliver the full experience of cannabis paralleling the onset and offset profiles of smoking.
NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NetworkNewsAudio - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Sproutly Canada, Inc. (SRUTF) (CSE:SPR) (38G.F), a client of NNW focused on becoming the leading supplier to the cannabis beverage and edibles market. NNW’s Stuart Smith introduces Sproutly president and CEO Keith Dolo in an interview that highlights the company’s strategy to pave a leading-edge in the cannabis industry. Dolo explains Sproutly’s mission to become the leading supplier to the cannabis beverage and edibles market.
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, releases a sector snapshot looking at the race for positioning in the future cannabis beverage space, with companies targeting key executives from the beverage industry as well as expanding with corporate acquisitions in the alcoholic and non-alcoholic beverage sector. High expectations on the passing of the US 2018 Farm Bill, as well as Canada’s anticipated edibles roll-out in 2019, have pushed cannabis infused beverage companies to continue to add to their company rosters ensuring they are fully prepared to seize the massive CBD beverage market in Canada, the US and internationally. Looking to the future, Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (38G.F), a licensed cannabis producer in Canada that has secured a natural water soluble technology to redefine cannabis beverages, just announced two new hires from the beverage sector, adding to their already seasoned team.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that Michael Bellas, CEO and founder of Beverage Marketing Company (www.beveragemarketing.com) has joined the Company’s board of directors. Mr. Bellas is a seasoned beverage executive who brings over 45 years of experience working with leading beverage companies across all beverage categories. “Mr. Bellas is among the most respected names in the beverage industry and we are extremely pleased that he has joined our board of directors,” said Keith Dolo, President and CEO of Sproutly.
POINT ROBERTS, Wash. and LAS VEGAS, Nov. 19, 2018 (GLOBE NEWSWIRE) -- www.Investorideas.com, a global news source covering marijuana and hemp stocks and its cannabis podcast site www.potcasts.ca report from Las Vegas at this year’s biggest MJBizCon show to date, from the first ever Podcaster’s Row. Today’s special edition features an interview with Dr. Arup Sen, the Chief Science Officer and Member of the Board of Directors for Sproutly Canada Inc. (CSE:SPR) (OTCQB:SRUTF) (38G.F). Dr. Sen sat down with Investor Ideas to discuss Sproutly’s patent-pending APP technology and how this scientific breakthrough could transform the cannabis beverage industry, as well as his role as Chief Science Officer in the company.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that it has entered into a letter of intent with Global Canna Labs Limited (“Global Canna Labs”), the Caribbean’s largest medical cannabis producer, to establish a joint venture for the purpose of developing, producing, distributing, marketing and selling cannabis infused beverages, edibles and topical products derived from Sproutly’s fully licensed, APP Technology (the “LOI”). “Partnering with Global Canna Labs on this joint venture allows Sproutly to expand its business outside of Canada with a leading, low cost cannabis cultivator in Jamaica that has proven distribution across the Caribbean and expanding into the European Union,” said Keith Dolo, President and Chief Executive Officer.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that it has completed the development and formulation of an initial portfolio of functional beverages with its proprietary naturally water soluble cannabinoids (“Infuz2O”). The Company is currently in the midst of medicinal and adult-use brand development, including its functional beverage line. The initial beverages are anticipated to be ready for consumers if and when Health Canada allows consumer beverage products to be legal for sale.
Sproutly Canada, Inc. (SPR.CN) (38G.F) (SRUTF) (“Sproutly" or the “Company”) is pleased to announce that it has closed its previously announced bought deal offering, including the partial exercise of the underwriters’ over-allotment option in the form of convertible debenture special warrants of the Company (the “CD Special Warrants”). A total of 10,750 CD Special Warrants at a price per CD Special Warrant of $1,000 and 15,400,000 equity special warrants of the Company (the “Equity Special Warrants”) at a price per Equity Special Warrant of $0.65 were issued for aggregate gross proceeds of approximately $20.7 million (the “Offering”).
VANCOUVER, Sept. 26, 2018 /CNW/ - Sproutly Canada, Inc. (CSE:SPR.CN - News) (FRA:38G.F - News) ("Sproutly" or the "Company") is pleased to announce that it has entered into a letter of engagement with Canaccord Genuity Corp. to act as lead underwriter and sole bookrunner ("Canaccord Genuity") under which Canaccord Genuity has agreed to purchase 10,000 convertible debenture special warrants of the Company (the "CD Special Warrants") on an underwritten basis at a price per CD Special Warrant of $1,000 for aggregate gross proceeds of $10 million (the "CD Offering"). Canaccord Genuity has also agreed to purchase 15,400,000 equity unit special warrants of the Company (the "Equity Unit Special Warrants") on an underwritten basis at a price per Equity Unit Special Warrant of $0.65 for aggregate gross proceeds of approximately $10 million (the "Equity Unit Offering").